8-K: Hydrofarm Reports Q4 2025 Loss Amid Impairment, Debt Default

Hydrofarm Holdings Group announced a significant net loss of $242.2 million in Q4 2025, driven by a large impairment charge and a recent default on its Term Loan.

Summary

• Net sales decreased 32.7% to $25.1 million in Q4 2025 compared to $37.3 million in the prior year period, primarily due to a 27.3% decline in volume/mix and a 5.6% decrease in price.
• Full Year 2025 net sales decreased to $134.252 million from $190.288 million in 2024.
• Net loss increased significantly to $242.2 million in Q4 2025, compared to $17.5 million in Q4 2024, primarily due to a non-cash impairment charge of $232.2 million attributable to intangible assets.
• Full Year 2025 net loss was $289.790 million, compared to $66.717 million in 2024.
• Adjusted EBITDA improved to $(4.9) million in Q4 2025 from $(7.3) million in the prior year period.
• Gross Profit Margin increased to 8.5% of net sales (GAAP) and Adjusted Gross Profit Margin increased to 15.4% of net sales in Q4 2025.
• SG&A expense decreased by 43.5% and Adjusted SG&A expense decreased by 18.9% in Q4 2025, marking the 14th consecutive quarter of year-over-year expense reductions.
• Cash and cash equivalents were $6.3 million as of December 31, 2025, down from $26.111 million at December 31, 2024.
• On February 4, 2026, the Company deferred an interest payment of approximately $2.8 million on its Term Loan, resulting in an event of default and interest accruing at an additional 2% per annum.
• The Term Loan principal balance of $114.4 million was reclassified to current portion of long-term debt as of December 31, 2025, due to the event of default.
• The Revolving Credit Facility was terminated on February 17, 2026.
• The Company is exploring strategic alternatives to strengthen its liquidity and capital structure and is engaged in ongoing discussions with Term Loan lenders.
• Substantial completion of the consolidation of U.S. manufacturing facilities into one location and reduction of U.S. distribution centers to two locations has been achieved as part of restructuring efforts.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as highly negative due to the substantial net loss driven by a massive impairment, significant revenue decline, and critical liquidity issues including a debt default and termination of a credit facility, indicating severe financial distress and a going concern risk.

Positives

• Gross Profit Margin increased to 8.5% (GAAP) and 15.4% (Adjusted) in Q4 2025, driven by higher sales of proprietary brands and improved productivity.
• SG&A expense decreased by 43.5% (GAAP) and Adjusted SG&A decreased by 18.9% in Q4 2025, representing the 14th consecutive quarter of meaningful year-over-year expense reductions.
• Adjusted EBITDA improved to $(4.9) million in Q4 2025 compared to $(7.3) million in the prior year period, related to higher Adjusted Gross Profit and lower Adjusted SG&A expenses.
• Substantial completion of the consolidation of U.S. manufacturing facilities into one location and reduction of U.S. distribution centers to two locations, aimed at further cost reduction and operational right-sizing.

Negatives

• Net sales decreased 32.7% in Q4 2025 to $25.1 million, primarily due to a 27.3% decline in volume/mix of products sold related to industry oversupply, and a 5.6% decrease in price.
• Net loss significantly increased to $242.2 million in Q4 2025, primarily due to a $232.2 million non-cash impairment charge on intangible assets.
• Cash and cash equivalents decreased from $26.111 million at December 31, 2024, to $6.309 million at December 31, 2025.
• Cash used in operating activities was $(4.0) million and Free Cash Flow was $(4.3) million during Q4 2025, a decrease from the prior year period.
• An event of default occurred on the Term Loan due to the deferral of an approximately $2.8 million interest payment on February 4, 2026, leading to interest accruing at a rate 2% per annum in excess of the otherwise payable rate.
• The Revolving Credit Facility was terminated on February 17, 2026.
• Total current liabilities significantly increased to $140.033 million at December 31, 2025, from $34.987 million at December 31, 2024, largely due to the reclassification of the Term Loan.
• Total stockholders (deficit) equity became negative $(63.296) million at December 31, 2025, from positive $223.722 million at December 31, 2024.

Risks

• The Company's ability to continue as a going concern.
• The Company's level of indebtedness.
• The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which has materially adversely impacted the Company's sales and other results of operations and may continue to do so.
• If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional substantial impairment charges and/or inventory and accounts receivable reserves, and ultimately may face liquidity challenges.
• The Company's current and future debt facilities may limit the operation of the Company's business, including restricting its ability to sell products directly to the cannabis industry.
• Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive.
• Interruptions in the Company's supply chain could adversely impact expected sales growth and operations.
• Increased prices and inflation could adversely impact the Company's performance and financial results.
• Global political and economic conditions, including the imposition of potential tariffs, could increase the costs of the Company's products and adversely impact competitiveness and financial results.
• The Company may be unable to meet the continued listing standards of Nasdaq.
• The Company's restructuring activities may increase expenses and cash expenditures, and may not have the intended cost saving effects.
• The highly competitive nature of the Company's markets could adversely affect its ability to maintain or grow revenues.
• Certain of the Company's products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company's products.
• The market for the Company's products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers.
• Compliance with government laws and regulations, including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities, could increase the Company's costs of doing business or limit its ability to market all of its products.
• Damage to the Company's reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business.
• If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed.
• The Company's operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack.
• The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to its business.
• Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company's business and results of operations.

Future Outlook

The company is focused on positioning the business to drive high-quality revenue streams, improved profitability, and strengthen its financial position. It remains committed to reducing costs and improving productivity through operational changes, facility footprint consolidation, headcount reduction, and focusing sales efforts on proprietary brand offerings.

Management Comments

• "In the fourth quarter we continued to execute against our strategy and achieved our best proprietary sales mix quarter of 2025."
• "Despite this sales mix improvement, lower volumes hindered our Adjusted Gross Profit Margin in the quarter."
• "We reduced Adjusted SG&A expense by 18.9% compared to the fourth quarter of 2024, representing our 14th consecutive quarter of meaningful year-over-year expense reductions."
• "To further reduce costs and right size our operations, we made significant progress towards our previously announced restructuring plan."
• "We are now substantially complete with the consolidation of our U.S. manufacturing facilities into one location, and further reduced our U.S. distribution centers down to two locations."
• "We are focused on positioning the business to drive high quality revenue streams, improved profitability, and strengthen our financial position."

Industry Context

StockSavvy.ai notes that Hydrofarm's significant sales decline and substantial impairment charge are largely attributed to industry oversupply and decreasing prices in the agricultural and cannabis sectors, reflecting broader challenges faced by suppliers to these markets. The company's strategic focus on cost reduction, operational streamlining, and proprietary brands is a common response to such severe market pressures, aiming to regain stability in a difficult environment.

Legal Proceedings

• Severance and other charges for Q4 and FY 2025 and 2024 primarily related to estimated net legal costs related to certain litigation and severance charges.
• Other income, net for Q4 and FY 2024 included a cash settlement arising from an outstanding litigation matter of a previously acquired entity.

Stakeholder Impact

• Shareholders: Face significant dilution risk if equity financing is pursued due to depressed stock prices; substantial net loss and negative equity could erode shareholder value.
• Creditors (Term Loan Lenders): An event of default on the Term Loan has occurred, leading to increased interest rates and ongoing discussions regarding the company's financial position and potential restructuring.
• Employees: Headcount reductions are explicitly mentioned as part of the company's restructuring initiatives to reduce costs.
• Customers: The company maintains dedication to customer service while focusing on proprietary brands and operational changes, which may impact product offerings or availability.
• Suppliers: Operational changes, facility consolidation, and cost reductions could potentially impact supplier relationships or volumes.

Next Steps

• Continue executing against the strategy to drive high-quality revenue streams, improve profit margins, and strengthen financial position.
• Further reduce costs and improve productivity within the organization.
• Implement operational changes, consolidate facility footprint, reduce headcount, and focus sales efforts on proprietary brand offerings.
• Explore strategic alternatives to strengthen liquidity and capital structure.
• Engage in ongoing discussions with Term Loan lenders.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a massive net loss driven by a $232.2 million impairment, a significant revenue decline, negative cash flow, and critical liquidity issues including a debt default and termination of its revolving credit facility. The ability to continue as a going concern is explicitly listed as a risk. While management is pursuing restructuring and cost reductions, the immediate financial position is highly precarious, making the stock a strong sell for investors.

Keywords

Hydrofarm, HYFM, hydroponics, controlled environment agriculture, CEA, financial results, Q4 2025, full year 2025, net sales, net loss, Adjusted EBITDA, impairment charge, debt default, liquidity, restructuring, cannabis industry, agricultural supplies